BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Fuji
Boehringer Ingelheim
QuintilesIMS
Deloitte
Harvard Business School
Citi
Mallinckrodt
Covington
Dow

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086008

« Back to Dashboard

NDA 086008 describes ALPHADERM, which is a drug marketed by Bioglan and is included in one NDA. Additional details are available on the ALPHADERM profile page.

The generic ingredient in ALPHADERM is hydrocortisone; urea. There are sixty-four drug master file entries for this compound. Additional details are available on the hydrocortisone; urea profile page.
Summary for 086008
Tradename:ALPHADERM
Applicant:Bioglan
Ingredient:hydrocortisone; urea
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength1%;10%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Moodys
Merck
Harvard Business School
Johnson and Johnson
AstraZeneca
Medtronic
McKinsey
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot